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ISSIntroduction: Scanty data exist on the phenotype and functionality of invariant natural
killer T (iNKT) cells in HIV-infected (HIVþ) patients.
Methods: By flow cytometry, we studied iNKT cells from 54 HIVþ patients who started
combined antiretroviral therapy and had undetectable viral load for more than 1 year.
Twenty-five maintained a CD4þ/CD8þ ratio less than 0.4, whereas 29 reached a ratio
more than 1.1; 32 age-matched and sex-matched patients were healthy controls (CTR).
Results: Patients with low ratio had lower percentage of CD4þ iNKT cells compared with
patientswith high ratio and higher CD8þ iNKT cell percentage; double-negative iNKT cells
were lower in HIVþ patients compared with CTR. Patients with low ratio had higher
percentage of CD4þ and double-negative iNKT cells expressing CD38 and HLA-DR
compared with patients with high ratio. CD4þ iNKT cells expressing PD-1 were higher
in patients with CD4þ/CD8þ ratio less than 0.4, whereas double-negative iNKT cells
expressing PD-1were lower comparedwith patientswith ratiomore than 1.1. Patientswith
low ratio had higher CD4þ iNKT cells producing IL-17, CD8þ iNKT cells producing IFN-g,
TNF-a or IFN-g and TNF-a, and double-negative iNKT cells producing IL-17 or IL-17 and
IFN-g compared with CTR. Activated CD4þ (or CD8þ) T cells correlated with activated
CD4þ (orCD8þ) iNKTcells, aswell as thepercentagesofCD4þ (orCD8þ) Tcellsexpressing
PD-1 was correlated to that of CD4þ (or CD8þ) iNKT cells expressing PD-1.
Conclusion: LowCD4þ/CD8þ ratio despite effective combined antiretroviral therapy is
associated with altered iNKT cell subsets, enhanced activation, and prominent Th1/
Th17 proinflammatory profile.
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2 AIDS 2016, Vol 00 No 00with low ratio are characterized by altered T-cell
subsets, high CD8þ T-cell activation, and increased
risk of non-AIDS-related morbidity and mortality
[1,2]. The mechanisms at the basis of the failure of
immune recovery in these patients are not well
understood, but likely include those involved in the
regulation of T-cell homeostasis. Among such mech-
anisms, those based upon invariant natural killer T
(iNKT) cells have never been investigated in detail.
iNKT cells are innate-like lymphocytes that recognize
glycolipid antigens presented by major histocompat-
ibility complex class-I-related glycoprotein CD1d and
exert important immunoregulatory functions [3–5].
These cells represent about 0.01–1.0% of peripheral
blood mononuclear cells (PBMCs) and are characterized
by the presence of a semi-invariant T-cell receptor
(iTCR), formed by a Va24Ja18 a-chain coupled with a
Vb11 b-chain [6]. Upon stimulation, this rare popu-
lation rapidly produces proinflammatory and/or antiin-
flammatory cytokines able to orchestrate innate
immunity through the recruitment and activation of
different types of effector cells (NK cells and dendritic
cells) as well as B and T cells [7–11]. iNKT cells can be
divided into different subsets on the basis of the
expression of CD4þ and CD8þ; in turn, each subset is
functionally distinct: CD4þ subset mainly produces Th2
cytokines, whereas CD8þ and CD4CD8 (double-
negative) iNKT cells are characterized by the production
of Th1 cytokine and a strong cytolytic activity [12].
The frequency and activity of iNKT cells have been
studied in several acute and chronic infections, including
HIV. In this case, it was shown that iNKT cells are highly
susceptible to the infection and constitute a considerable
viral reservoir [13]. Concerning their subpopulations,
CD4þ iNKT cells are rapidly depleted in the gut after
primary infection and are further lost in the following
phases [14], but are preserved in gut-associated lymphoid
tissue (GALT). In the GALT, iNKT cells are character-
ized by production of Th2 cytokines [15]. Circulating
iNKT cells are functionally impaired and express high
levels of PD-1 [16], most of them produce IFN-g [16],
and a high expression of CD161 is associated with poor
cytokine secretion [17]. To note, a successful cART
induces a rapid recovery of NKT cells [18], but the
reconstitution of the pool of CD4þ iNKT cells remains
delayed [19].
The phenotype and the polyfunctionality of iNKT cells
and their subsets have never been investigated in details
in patients with different CD4þ/CD8þ ratio after
successful cART. Thus, we have characterized iNKT
cells in patients with low and normal CD4þ/CD8þ
ratio and evaluated their capacity to produce in vitro
proinflammatory or anti-inflammatory cytokines upon
stimulation.Materials and methods
Patients
The study was approved by the Institutional Review
Board of the Department of Surgery, Medicine, Dentistry
and Morphological Sciences of the University of Modena
and Reggio Emilia. We enrolled a total of 54 HIVþ
patients with undetectable viral load (<50 copies/ml),
and in particular 25 patients (24 men) who displayed a
CD4þ/CD8þ ratio less than 0.4 have been taking cART
since 7.12 5.50 years (group A). They were compared
with 29 patients (20 men) with a CD4þ/CD8þ ratio
more than 1.1 who had been under cART since
7.47 5.83 years (group B). As controls, we studied a
total of 32 age-matched and sex-matched healthy donors
(CTR). Patients’ characteristics and treatments are
reported in Table 1.
Polychromatic flow cytometry
To identify circulating iNKT cells, whose percentage in
peripheral blood is typically less than 1%, and in HIVþ
patients even less, it is mandatory to acquire a huge
number of cells [20,21]. Thus, up to 50 ml of venous
blood was collected from each patient into ethylenedia-
minetetraacetic acid tubes. PBMCs were isolated by
Ficoll-Hypaque density gradient according to standard
procedures and immediately processed for immunophe-
notypic analysis.
Freshly isolated PBMCs were stained with fluorochrome-
labeled mAbs at previously defined optimal concen-
trations. The following mAbs were used to identify iNKT
cells: anti-Va24Ja18 TCR-PE (Becton Dickinson, San
Jose´, California, USA), -CD161-PC7 (Beckman Coulter,
Brea, California, USA), -CD4-AF700, -CD8-APC-Cy7,
-CD3-PE-Cy5, -HLA-DR-FITC, -CD38-BV605, and
anti-programmed cell death protein-1 (PD-1, or CD279)-
BV421 (from eBiolegend, San Diego, California, USA).
PBMCs were incubated for 20 min at room temperature,
washed with Stain Buffer (Becton Dickinson), and
immediately analyzed. A minimum of 10 million cells
were acquired on an acoustic focusing flow cytometer
(Attune NxT; ThermoFisher, Eugene, Oregon, USA).
In-vitro stimulation
For functional assays, freshly isolated PBMCs were
stimulated for 4 h at 37 8C in 5% CO2 atmosphere with
phorbol myristate acetate (PMA; final concentration
200 ng/ml, Sigma Aldrich, St. Louis, Missouri, USA)
and ionomycin (1mg/ml, Sigma Aldrich) in complete
culture medium (RPMI 1640 supplemented with 10%
fetal bovine serum and 1% each of L-glutamine, sodium
pyruvate, nonessential amino acids, antibiotics, 0.1 mol/l
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, and
55mmol/l b-mercaptoethanol). For each sample, up to 15
million cells were left unstimulated as negative control and
up to 15 million cells were stimulated. All samples were
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brefeldin A (Golgi Plug, Becton Dickinson). Cells were
stained with Live Dead AQUA (ThermoFisher) and
surface mAbs anti-Va24Ja18 TCR-PE (Becton Dick-
inson), -CD3-PE-Cy5, -CD4-AF700, and -CD8-APC-
Cy7 (Biolegend). Cells were washed with Stain Buffer
(Becton Dickinson), fixed and permeabilized with the
Cytofix/Cytoperm buffer set (Becton Dickinson) for
cytokine detection [22]. Finally, cells were stained with
mAbs anti-IL-17A-BV421, anti-TNF-a-BV605, IFN-g-
FITC, and IL-4-APC according to standard procedures.
Up to 15 million cells per sample were acquired by an
acoustic focusing flow cytometer (Attune NxT).Flow cytometry
Data were acquired in list mode using Attune NxT 2.1
software and analyzedbyFlowJo9.9 (TreeStar Inc.,Ashland,
Oregon, USA) [23]. Samples were compensated by software
after acquisition. Single staining and Fluorescence Minus
One controls were performed for all mAbs of the panel to set
proper compensation and define positive signals. ‘Simplified
Presentation of Incredibly Complex Evaluations’ (SPICE,
kindly provided by Dr Mario Roederer, NIH, Bethesda,
Maryland, USA) software 5.3 was used to graphically depict
polychromatic flow cytometry data [24,25]. For the
functional analysis of iNKT cells, a threshold of 0.05%Table 1. Clinical characteristics of the patients, and type of therapy.
CTR
G
CD4þ/C
Patients N (men) 32 (17)
CD4þ/CD8þ ratioa 1.650.74 <0
Age (years)a 47.288.05 51.0
Time of HAART (years)a  7.1
CD4þ cell count (cells/ml)a 773300 47
CD8þ cell count (cell/ml)a 479197 115
Viral load <50 copies/ml [N (%)] 2
HAART regimen (N)
3TC/ATV/RAL
3TC/ATV/RTV
3TC/DRV/RTV
3TC/DTG
3TC/LPV/RTV
ABC/3TC/ATV/RTV
ABC/3TC/DRV/RTV
ABC/3TC/DTG
ABC/3TC/EFV
ABC/3TC/NEV
ABC/ZDV/3TC/LPV/RTV
ATV/RTV/MVC
ZDV/DRV/RTV/MVC
DRV/RTV
DRV/RTV/RAL
TDF/FTC/ATV/RTV
TDF/FTC/DRV/RTV
TDF/FTC/EFV
TDF/FTC/ELV/COBI
TDF/FTC/RPV
aMean SD. ABC, abacavir; ATV, atazanavir; COBI, cobicistat; DRV, da
emtricitabine; LPV, lopinavir; MVC, maraviroc; NEV, nevirapine; RAL, ra
fumarate; ZDV, zidovudine.was set on the basis of the distribution of negative values
generated after background subtraction [26,27].
Statistical analysis
Quantitative variables were compared with nonpara-
metric Mann–Whitney U test. The correlations between
clinical parameters and molecular data were performed by
Spearman correlation test and linear regression analysis.
P values less than 0.05 were considered statistically
significant. Permutation test was used to compare SPICE
pies. The results were confirmed with rank sum test. The
Bonferroni correction was applied for comparison
between CTR vs less than 0.4 group or CTR vs more
than 1.1 group. Data are represented as mean SEM.
Statistical analyses were performed using Prism 6.0
(Graphpad Software Inc., La Jolla, California, USA).Results
Identification of invariant natural killer T cells
among freshly isolated peripheral blood
mononuclear cells
The gating strategy used to identify iNKT cells with their
subsets is shown in Fig. 1a. Freshly isolated lymphocytes
were identified by their physical parameters [forward sideroup A
D8þ ratio <0.4
Group B
CD4þ/CD8þ ratio >1.1 P (A vs B)
25 (24) 29 (20) NS
.4 >1.1 <0.001
811.15 47.1410.11 NS
25.50 7.475.83 NS
9179 913355 <0.0001
5463 616279 <0.0001
5 (100) 29 (100) NS
0 1
1 0
4 2
0 2
0 1
1 1
1 2
1 1
1 2
0 2
1 0
1 0
1 0
0 3
2 0
2 1
1 0
5 7
0 1
3 3
runavir; DTG, dolutegravir; EFV, efavirenz; ELV, elvitegravir; FTC,
ltegravir; RPV, rilpivirine; RTV, ritonavir; TDF, tenofovir disoproxil
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Fig. 1. Phenotype of invariant natural killer T cells in healthy patients and HIVR patients with ratio less than 0.4 (group A) and
more than 1.1 (group B). (a) Gating strategy used to identify circulating invariant natural killer T cells. Lymphocytes were identified
on the basis of physical parameters (forward side scatter-H and side scatter (SSC)-H, then forward side scatter-H and forward side
scatter-A), debris and doubles were removed and invariant natural killer T lymphocytes were identified on the basis of the
expression of CD3 and Va24Ja18. Then, CD4þ, CD8þ, and CD4CD8 (double-negative) invariant natural killer T cells were
identified. In these three subpopulations, the expression of PD-1, CD161, and activation markers CD38 and HLA-DR was
analyzed. In controls (N¼32), group A (N¼25) and group B (N¼ 29): (b) percentage of circulating invariant natural killer T cells,
(c) absolute number of circulating invariant natural killer T cells/ml blood, (d) percentage of circulating CD4þ invariant natural
killer T cells, (e) percentage of circulating CD8þ invariant natural killer T cells, (f) percentage of circulating CD4CD8 invariant
natural killer T cells, (g) percentage of CD4þ invariant natural killer T cells expressing CD161, (h) percentage of CD8þ invariant
natural killer T cells expressing CD161, and (i) percentage of double-negative invariant natural killer T cells expressing CD161. In
group A (N¼13) and group B (N¼ 15): (l) percentage of circulating activated CD4þ invariant natural killer T cells, (m) percentage
of circulating activated CD8þ invariant natural killer T cells, (n) percentage of circulating activated double-negative invariant
natural killer T cells, (o) percentage of circulating CD4þ invariant natural killer T cells expressing PD-1, (p) percentage of
circulating CD8þ invariant natural killer T cells expressing PD-1, and (q) percentage of circulating double-negative invariant
natural killer T cells expressing PD-1. Quantitative variables were compared with nonparametric Mann–Whitney U test.
P< 0.05, P<0.01, P<0.001, and P<0.0001. Data are represented as the mean SEM.
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6 AIDS 2016, Vol 00 No 00scatter (FSC)-H vs SSC-H], doublets were removed from
the analysis considering FSC)-H and FSC-Area, and then
iNKT cells were selected on the basis of the expression of
CD3 and Va24Ja18 (using the 6B11 clone, which
specifically binds the invariant CDR3 region of the
iTCR). Among iNKT cells, we were able to identify
CD4þ iNKT cells, CD8þ iNKT cells, and double-
negative iNKT cells. Finally, PD-1 expression, activation
status (by analyzing CD38 and HLA-DR), and CD161
expression were evaluated on different subpopulations of
iNKT cells.
Changes in invariant natural killer T cell
subpopulations in patients with low or high
CD4R/CD8R ratio
Considering iNKT cells as percentage of total T
lymphocytes, both groups of HIVþ patients and healthy
patients displayed a similar percentage and absolute
number of iNKT cells (Fig. 1b and c, P¼NS). The
percentage of total iNKT cells expressing CD161, not
shown in the figure, was lower in both groups of HIVþ
patients (group A: 9.43 2.87 and group B:
13.10 3.84) than in CTR (56.90 5.28, P< 0.001
in both cases).
We analyzed different subpopulations of iNKT cells, and
we observed a significant decrease in CD4þ iNKT cells in
group A compared with group B (Fig. 1d, P< 0.05). On
the contrary, the percentage of CD8þ iNKT cells was
higher in group A when compared with CTR (Fig. 1e,
P< 0.001) and with group B (Fig. 1e, P< 0.001). The
percentage of double-negative iNKT cells was lower in
both groups of HIVþ patients if compared with healthy
patients (Fig. 1f, group A vs CTR: P< 0.0001 and group
B vs CTR: P< 0.01). Finally, the percentages of all
subpopulations (i.e., CD4þ, CD8þ, and CD4CD8
subsets) of iNKT cells expressing CD161 were signifi-
cantly lower in both groups of HIVþ patients when
compared with CTR (Fig. 1g–i, P< 0.0001 in all cases).
CD4R invariant natural killer T cells in group A
displayed enhanced activation and exhaustion
We could analyze the activation status and the expression
of PD-1 in different iNKT cell subpopulations in 13
patients of group A and 15 of group B. Group A displayed
higher percentage of activated (CD38þ and HLA-DRþ)
CD4þ iNKT cells if compared with group B (Fig. 1l,
P< 0.05). Patients with ratio less than 0.4 and more than
1.1 displayed similar percentage of activated CD8þ iNKT
cells (Fig. 1m, P¼NS), whereas the percentage of
activated CD4CD8 iNKTwas higher in patients with
low ratio (Fig. 1n, P< 0.05). The percentage of CD4þ
iNKT cells expressing PD-1 was higher in patients with
ratio less than 0.4 (Fig. 1o, P< 0.05). Similar percentage
was found among CD8þ iNKT cell subset PD-1þ
(Fig. 1p, P¼NS) of different groups of patients. On the
contrary to the CD4þ iNKT cell subset, the percentage of
CD4CD8 iNKT cells expressing PD-1 was higher inpatients with ratio more than 1.1 compared with patients
with ratio less than 0.4 (Fig. 1q, P< 0.05).
Production of cytokines by invariant natural
killer T cells after in-vitro stimulation
We investigated the ability of iNKT cells to produce
simultaneously different cytokines. The gating strategy is
shown in Fig. 2a. Lymphocytes were selected according
to physical parameters (FSC-H and SSC-H). Doublets
and fluorochrome aggregates were removed by electronic
gates (as in the plots ‘FSC-Avs FSC-H’ and ‘Va24Ja18 vs
TIME’), and dead cells were identified on the basis of the
SSC-H and negativity for Live/Dead. Among this
population, iNKT cells were identified as CD3þ,
Va24Ja18þ cells. Then, the expression of CD4þ and
CD8þ was analyzed among iNKT lymphocytes. In each
subset of CD4þ, CD8þ, or CD4CD8 (double-
negative) iNKT cells, the intracellular content of
TNF-a, IFN-g, IL-4, and IL-17 was simultaneously
detected. We identified both the ‘total’ response, that is,
the sum of all cells positive for at least one marker (this
provides the overall ‘frequency’ of responding cells) and
the ‘qualitative’ response, which describes the contri-
bution of each functional pattern to the total
specific response.
CD4R invariant natural killer T cells from HIVR
patients with ratio less than 0.4 display a skewed
Th17 profile, whereas CD8R invariant natural
killer T cells mainly produce TNF-a and IFN-g
In Fig. 2b, the overall polyfunctional response of
different subsets of iNKT cells in different groups of
patients and in controls is represented as pie chart.
Permutation test performed on 10 000 events revealed
that a highly significant difference in the overall
production of cytokines was detectable in CD4CD8
 iNKT cells. Changes among CD4þ iNKT cells were
at the limit of statistical significance, whereas CD8þ
iNKT cells behaved in a similar manner among
the groups.
A more detailed analysis revealed that CD4þ iNKT cells
of group A were characterized by a higher production of
IL-17 when compared with group B (Fig. 2c,
P< 0.025) or healthy controls (Fig. 2c, P< 0.001).
Concerning CD8þ iNKT cells, we found that group A
had higher percentage of cells producing IFN-g
(Fig. 2d, P< 0.025) or TNF-a (Fig. 2e, P< 0.025)
compared with CTR. Furthermore, these patients also
showed more CD8þ iNKT cells able to simultaneously
produce TNF-a and IFN-g in comparison with CTR
(Fig. 2f, P< 0.025). Finally, group A was characterized
by higher percentages of double-negative iNKT cells
that produced IL-17 (Fig. 2g, P< 0.025) and IL-17 and
IFN-g (Fig. 2h, P< 0.025) when compared with CTR.
Regarding Th2 cytokine production, we did not find
any production of IL-4 from different subsets of
iNKT cells.
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by invariant natural killer T cells. Several electronic, consecutive gates were set to exclude doublets, dead cells, and aggregates on
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scatter-A, Va24Ja18 vs Time, and SSC-H vs Live Dead). invariant natural killer T cells were recognized on the basis of the
expression of CD3 and Va24Ja18. Among this population, according to CD4þ and CD8þ expression, different subsets were
identified (CD4þ, CD8þ, and CD4CD8). Among these invariant natural killer T subpopulations, the production of IL-4, IL-17,
TNF-a, and IFN-g was quantified after 4 h stimulation with phorbol myristate acetate/ionomycin. Nine-color flow cytometry was
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8 AIDS 2016, Vol 00 No 00Activation and exhaustion run in parallel in cells
of the innate and adaptive immunity
We finally analyzed the correlation between activation
markers, PD-1 expression, and cytokine production
among CD4þ or CD8þ T cells and CD4þ or CD8þ
iNKT cells. Our data revealed a strong correlation
between activated CD4þ T cells and activated CD4þ
iNKT cells (Fig. 3a, R2¼ 0.42, P¼ 0.0002), as well as
between activated CD8þ T cells and activated CD8þ
iNKT cells (Fig. 3b, R2¼ 0.56, P< 0.0001). The
percentage of CD4þ T cells expressing PD-1 was
positively correlated with CD4þ iNKT cells expressing
PD-1 (Fig. 3c, R2¼ 0.60, P< 0.0001). We also noted a
similar, striking correlation regarding CD8þ cells
(Fig. 3d, R2¼ 0.63, P< 0.0001).
Moreover, we compared the production of cytokines by
CD4þ T cells or CD8þ T cells with the production by
CD4þ or CD8þ iNKT cells. Our data revealed that there
was a positive correlation between the percentage of
CD4þ T lymphocytes producing TNF-a and that of
CD4þ iNKT cells producing TNF-a (Fig. 3e, R2¼ 0.63,
P< 0.0001). Similarly, a correlation existed between the
percentage of CD8þ T cells producing IFN-g and that of
CD8þ iNKT cells producing IFN-g (Fig. 3f, R2¼ 0.74,
P< 0.0001).
Thus, these findings suggested that high and similar levels
of activation are simultaneously present in different
subsets of innate-like lymphocytes and in those that
belong to adaptive immunity.Discussion
The changes that occur in the immune system during
HIV infection are under investigation since the beginning
of the epidemics. Only recently, however, the develop-
ment of novel technologies has allowed a deeper analysis
of compartments that were almost unknown until a few
years ago. One of these compartments regards cells the
classification of which lies between innate and acquired
immunity, that is, iNKT cells (that are also defined ‘type Iused, acquiring a minimum of 10 million events per sample. (b) Po
killer T cells, as represented by ‘Simplified Presentation of Incred
production of each cytokine, pie slices the polyfunctional capacity
T cells, a threshold of 0.05% was set on the basis of the distributio
Statistical analysis was performed by permutation test. (c) Total IL-17
groups A and B, (d) total IFN-g production by CD8þ invariant natur
natural killer T cells, (f) IFN-g and TNF-a simultaneous product
production by double-negative invariant natural killer T cells, an
negative invariant natural killer T cells. (b)–(h) Are related to 26 c
Quantitative variables were compared with nonparametric Man
represented as the mean SEM.NKT cells’). Regarding HIV infection, few studies have
been performed on this peculiar T-cell family, that is
formed by different subsets, including that expressing
CD4þ (but not CD8þ) molecule, along with others
characterized by the presence of CD8þ only, the
coexpression of CD4þ and CD8þ, or the lack of both
coreceptors. This is the first study that, using a novel and
sophisticated cytometric approach, investigates the
number, phenotype, and polyfunctionality of iNKT cells
and their subtypes in HIVþ patients on cART who had
been able to restore or not to a normal CD4þ/CD8þ
ratio after successful treatment.
Patients with different CD4þ/CD8þ ratio after cART
displayed similar percentages of iNKT cells. Previous
studies reported that NKT cell frequency was signifi-
cantly reduced among HIVþ individuals [28–30], with a
specific depletion of CD4þ iNKT cells compared with
the CD4 subset [29]. In particular, this loss occurred
within the first year of infection, with a continuous
decline in the following 5 years. We could deeply
investigate also the CD4 subset of iNKT cells and could
evaluate the percentages of CD8þ and CD8 iNKT cells
as well, finding that the percentages of CD4þ and CD8þ
iNKT cells mirrored those of T cells and that there was a
marked reduction in double-negative iNKT cells in both
HIVþ patients with high or low CD4þ/CD8þ ratio.
We found that the expression of CD161 among iNKT
cells was reduced in both HIVþ patient groups if
compared with healthy patients. The expression of
CD161 identifies more activated and mature subsets able
to produce different cytokines such as IFN-g, TNF-a,
and IL-17 [31]. Data regarding the expression of CD161
among iNKT cells from HIVþ patients on cART are
discordant. It has been reported that iNKT cells from
HIVþ patients with bone and cardiovascular impairment
expressed high levels of CD161 and predominantly
secreted TNF-a [32]. However, in such study, the
number of iNKT cells under investigation was too low to
draw any statistically significant conclusion.
We found that HIVþ patients with CD4þ/CD8þ ratio
less than 0.4 were characterized by high levels of activatedlyfunctional response of different subsets of invariant natural
ibly Complex Evaluations’ software. Arcs represent the total
of cells. For the functional analysis of invariant natural killer
n of negative values generated after background subtraction.
production by CD4þ invariant natural killer T cells fromCTR,
al killer T cells, (e) total TNF-a production by CD8þ invariant
ion by CD8þ invariant natural killer T cells, (g) total IL-17
d (h) IFN-g and IL-17 simultaneous production by double-
ontrols, 25 patients in group A, and 27 patients in group B.
n–Whitney U test. P<0.05 and P<0.001. Data are
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Fig. 2. (Continued ).CD4þ iNKT cells and high levels of CD4þ iNKT cells
expressing PD-1 and that these percentages correlated with
thoseof activatedCD4þTcells andCD4þTcells expressing
PD-1. Increased expression of exhaustion marker PD-1 in
iNKT cells was reported among HIVþ individuals in one
study, but PD-1 levels were not significantly correlated with
IFN-g production nor with proliferative capacity; blocking
PD-1 did not restore iNKT cell function [15]. These could
suggest that these cells acquire an irreversibly exhausted
phenotype. However, it has to be considered that the
expression and functional impact of other inhibitory
receptors (such as the lymphocyte-activation gene 3) on
iNKTcell subsets duringHIV infection remaincontroversial
[33]. Recently, it has been observed that PD-1þNK cells
display impaired cytotoxic activity and cytokine pro-
duction, and that cytomegalovirus infection is correlated
to the amount of NK cells expressing PD-1 [34]. Further
analyses are needed to ascertain if such phenomenon also
involves the iNKT subset.
We demonstrate here that, in patients with low CD4þ/
CD8þ ratio, the persistent level of activation among
iNKT cells, the amount of IL-17-producing CD4þ
iNKT cells and of IFN-g-producing CD8þ iNKT cells
could reflect what happens in the whole T-cellcompartment. Activated iNKT cells produce multiple
cytokines that can influence the outcome of the infection
in favor of the host, although their potent activation may
contribute to the onset of an uncontrolled cytokine
storm, like that observed during sepsis [35]. It could be
hypothesized that one of the crucial aspects of iNKT cell
response to pathogens is the capacity to produce
cytokines in a very rapid but short manner, which is
typically followed by an extended time period of
unresponsiveness to reactivation. This refractory period
may represent a means to avoid chronic activation, thus
protecting the host against some of the negative effects of
iNKT cell activation, but potentially putting the host at
risk for secondary infections [35]. The biphasic response
of iNKT cells is thus of crucial importance for
understanding the role of these cells in immune responses
against infections [36]. Moreover, it has been shown that a
sphingolipid produced by the human commensal
Bacteroides fragilis can bind CD1d and modulate iNKT
cells, indicating that the gut microbiome influences their
post-thymic maturation. Thus, it is likely that iNKT cells
in the GALT could play an important role in limiting
microbial translocation and chronic pathologic immune
activation [15]. Further studies are needed to clarify
these aspects.
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Fig. 2. (Continued ).Even among individuals with minimal iNKT cell
depletion during HIV infection, the iNKT subset
displays functional impairment. Both CD4þ and CD4
iNKTs exhibit reduced proliferation and IFN-g, TNF-a,
and IL-4 secretion in response to different stimuli
[15,28,37], with variable restoration among cART
recipients. Here we show that iNKT cells from patients
with low CD4þ/CD8þ ratio display a pronounced Th1
and Th17 proinflammatory profile.
Finally, CD4þ/CD8þ ratio has become a marker of
interest for immune dysfunction among HIV-infectedpatients. Recently, it was well evidenced that a low
CD4þ/CD8þ ratio is a risk factor for clinical progression
and that CD4þ/CD8þ ratio could become an easy and
relatively inexpensive marker for clinicians to predict the
risk of serious non-AIDS-defining events and death
independently of CD4þ restoration [2]. We found that
such ratio can be associated with an impairment of iNKT
cells, and we can thus hypothesize that their Th1 and
Th17 profile, mirror of potent production of proin-
flammatory molecules, could contribute to the inap-
propriate and persistent immune system activation and to
the persistent inflammation typical of HIV infection [38].
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Fig. 3. In HIVR patients, activation and exhaustion markers are expressed in the same manner by innate-like cells and in cells
belonging to adaptive immunity. (a) Correlation between activated CD4þ T cells and activated CD4þ invariant natural killer T
cells (R2¼0.42, P¼0.0002, N¼28), (b) correlation between activated CD8þ T cells and activated CD8þ invariant natural
killer T cells (R2¼0.56, P<0.0001, N¼28), (c) correlation between CD4þ T cells expressing PD-1 and CD4þ invariant natural
killer T cells expressing PD-1 (R2¼0.60, P<0.0001, N¼19), (d) correlation between CD8þ T cells expressing PD-1 and CD8þ
invariant natural killer T cells expressing PD-1 (R2¼ 0.63, P<0.0001,N¼19), (e) correlation between percentage of CD4þ T cells
producing TNF-a and CD4þ invariant natural killer T cells producing TNF-a (R2¼0.63, P<0.0001, N¼52), and (f) correlation
between percentage of CD8þ T cells producing IFN-g and the percentage of CD8þ invariant natural killer T cells producing IFN-g
(R2¼0.74, P< 0.0001, N¼52). Spearman correlation test and linear regression analysis were used.Acknowledgements
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